glyXera is a Max Planck Society spin-off, specialized in high-throughput glycoanalysis.
glyXera provides a fast and reliable glycoanalysis utilizing a “real” high-throughput system (method/software/database) with superior performance and capacity compared to the glycoanalysis tools available up to now.
We offer our clients a sophisticated technology platform and our expertise with respect to glycoanalytical services, tailored to the specific needs of academia, clinics, pharmaceutical and food industries.
We guide you for better decisions and help you to perform better and faster during discovery phase, R&D, (clinical) trials and approval of your innovative products (biopharmaceuticals, vaccines, food additives, functional food, etc.), and QA/QC in your production stages. Standard operating procedures (SOP) and a comprehensive quality management system ensure reproducible analyses on highest levels and guarantees transparency through all processes.
Our clients include leading pharmaceutical, biotechnology and food companies throughout the world.